SCHEMBL31383943

SCHEMBL31383943

CON(C)C(=O)COC(C)c1c(Br)cccc1Br

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ FAAH O00519 1/20 0.34
▸ PDCD1 Q15116 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32
▸ PKM P14618 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TSHR P16473 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31383992 0.79 LMNA (0.37) MEN1KMT2ATDP1PKMHSD17B10
SCHEMBL38660431 0.72 KMT2A (0.39) MEN1KMT2ATDP1FAAHPKM
SCHEMBL30769458 0.71 NPC1 (0.44) SLC6A2SLC6A4SLC6A3RAB9A
SCHEMBL5043805 0.71 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL31018228 0.70 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL23977073 0.69 EED (0.36) MEN1KMT2ATDP1
SCHEMBL13032640 0.68 TAAR1 (0.43) MEN1KMT2ATDP1CYP2C19TSHR
SCHEMBL5043806 0.67 SLC6A4 (0.49) SLC6A2SLC6A4SLC6A3KMT2ATDP1
SCHEMBL27094112 0.67 ATM (0.37) MEN1KMT2ATDP1PDCD1CD274
SCHEMBL29994018 0.67 ATM (0.37) MEN1KMT2ATDP1PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064802-A1 INHIBITING HUMAN INTEGRIN α5β1 MORPHIC THERAPEUTIC, INC. (US) 2025-03-27 — — WO disclosed
Send feedback